← Eichor
Condition: Ild Synced from ClinicalTrials.gov · July 27, 2026

Recruiting studies: Ild

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease
Phase 2 · 5 location(s) · Vejle Hospital · NCT06714123LetS Get fUnctional! FuNctional Status in pEople With intersTitial Lung Disease
Phase N/A · 1 location(s) · Aveiro University · NCT06317831Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung
Phase 3 · 1 location(s) · University Hospital, Tours · NCT06549231Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland
Phase N/A · 1 location(s) · Royal College of Surgeons, Ireland · NCT06702228Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
Phase 2 · 1 location(s) · University of Alberta · NCT06053164Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging
Phase 3 · 1 location(s) · Anna Raciborska · NCT04943211Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients
Phase 2 · 1 location(s) · Anna Raciborska · NCT04943224Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT06036719A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With I
Phase 3 · 48 location(s) · Boehringer Ingelheim · NCT07366034A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Ant
Phase N/A · 1 location(s) · Royal Brompton & Harefield NHS Foundation Trust · NCT07332117End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Underg
Phase N/A · 1 location(s) · University of Modena and Reggio Emilia · NCT05098717Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Function
Phase N/A · 1 location(s) · University of Sydney · NCT06159660Nucleoside Therapy in Patients With Telomere Biology Disorders
Phase 1 · 1 location(s) · Suneet Agarwal · NCT06817590Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Phase 2 · 12 location(s) · Carl Allen · NCT04079179Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis
NA · 1 location(s) · Weill Medical College of Cornell University · NCT06811389An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Phase N/A · 23 location(s) · Liquidia Technologies, Inc. · NCT06129240Downhill Walking in IPF
NA · 1 location(s) · Saglik Bilimleri Universitesi · NCT06756230Immune Modulation by Exosomes in COVID-19
Phase N/A · 1 location(s) · University of Ulm · NCT05191381Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Phase 2 · 3 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05785065Connective Tissue Diseases and Lung Manifestations
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04095351Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
Phase 2 · 1 location(s) · Peter Caravan · NCT07572383Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Phase 1 · 4 location(s) · Wuhan Optics Valley Vcanbiopharma Co., Ltd. · NCT06230822Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases
Phase N/A · 1 location(s) · Assiut University · NCT06983366The Role of Standardized Training in the Diagnosis of Interstitial Lung Disease by Transbronchial Lung Cryobiopsy
NA · 1 location(s) · China-Japan Friendship Hospital · NCT06245954A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Pr
Phase 3 · 373 location(s) · Boehringer Ingelheim · NCT06238622Mechanisms of Familial Pulmonary Fibrosis
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT03437486Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
NA · 4 location(s) · Mayo Clinic · NCT06751069The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease
Phase N/A · 1 location(s) · University College, London · NCT07060079LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Phase 2 · 3 location(s) · OrphAI Therapeutics · NCT05798923Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Phase 4 · 21 location(s) · Hospices Civils de Lyon · NCT05841758
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.